World's Best Scientists 2026 revealed!

Alan J. Garber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alan J. Garber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Alan J. Garber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alan J. Garber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Alan J. Garber was affiliated with Baylor College of Medicine in the United States. Their research primarily focused on the field of Medicine, with a significant concentration in Endocrinology, Diabetes and Metabolism. Other areas of study included Surgery and Economics and Econometrics.

They contributed to the understanding and management of diabetes and cardiovascular health through their research on topics such as:

  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Systems, Economic Evaluations, Quality of Life

Alan J. Garber's recent scholarly output includes publications in the journal Endocrine Practice. Their notable papers were:

  • Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2020 Executive Summary (2020)
  • Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary (2020)

The scientist frequently collaborated with several colleagues, including:

  • Yehuda Handelsman
  • George Grunberger
  • Daniel Einhorn
  • Paul S. Jellinger
  • Jeffrey I. Mechanick

Throughout their career, Alan J. Garber contributed to advancing knowledge related to diabetes care algorithms, lipid management, and cardiovascular disease prevention protocols. Their research appeared predominantly in Endocrine Practice, indicating a consistent focus on clinical endocrinology topics.

Best Publications

  • Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Alan Garber;Robert Henry;Robert Ratner;Pedro A Garcia-Hernandez

  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

    W. Timothy Garvey;Jeffrey I. Mechanick;Elise M. Brett;Alan J. Garber

  • STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/ AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL

    Helena W. Rodbard;Paul S. Jellinger;Jaime A. Davidson;Daniel Einhorn

  • AACE comprehensive diabetes management algorithm 2013.

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

    Paul S. Jellinger;Yehuda Handelsman;Paul D. Rosenblit;Zachary T. Bloomgarden

  • Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

    Philip Raskin;Elsie Allen;Priscilla Hollander;Andrew Lewin

  • American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

    Yehuda Handelsman;Zachary T. Bloomgarden;George Grunberger;Guillermo Umpierrez

  • American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary

    Yehuda Handelsman;Jeffrey I. Mechanick;Lawrence Blonde;George Grunberger

  • American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

    Yehuda Handelsman;Jeffrey Mechanick;Lawrence Blonde;George Grunberger

  • Efficacy of Metformin in Type II Diabetes: Results of a Double-Blind, Placebo-controlled, Dose-Response Trial

    Alan J. Garber;Theodore G. Duncan;Anita M. Goodman;Donna J. Mills

  • Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

    Emanuele Bosi;Riccardo Paolo Camisasca;Carole Collober;Erika Rochotte

  • American College of Endocrinology position statement on inpatient diabetes and metabolic control.

    Alan J Garber;Etie S Moghissi;Edwin D Bransome;Nathaniel G Clark

  • The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.

    Ralph A. DeFronzo;Miguel N. Hissa;Alan J. Garber;Jorge Luiz Gross

  • CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.

    Alan J. Garber;Yehuda Handelsman;George Grunberger;Daniel Einhorn

  • Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Joshua I. Barzilay;Lawrence Blonde

  • CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.

    A J Garber;P E Cryer;J V Santiago;M W Haymond

  • Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

    Alan J Garber;Allen B King;Stefano Del Prato;Seamus Sreenan

  • Long-Acting Glucagon-Like Peptide 1 Receptor Agonists

    Alan J. Garber

Frequent Co-Authors

W. Timothy Garvey
W. Timothy Garvey University of Alabama at Birmingham
Irl B. Hirsch
Irl B. Hirsch University of Washington
Guillermo E. Umpierrez
Guillermo E. Umpierrez Emory University
Janet B. McGill
Janet B. McGill Washington University in St. Louis
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
Vivian Fonseca
Vivian Fonseca Tulane University
Michael H. Davidson
Michael H. Davidson University of Chicago
Edward S. Horton
Edward S. Horton Harvard Medical School
Lutz Birnbaumer
Lutz Birnbaumer National Institutes of Health
Robert R. Henry
Robert R. Henry University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not sure medical school is right for you, there are many other promising online options. The growing demand for skilled health professionals has expanded affordable, flexible ways to enter the field.

For those interested in managing patient data, pursuing a him degree online can lead to careers in health information management, records analysis, or data security. Another popular pathway is billing and coding classes online, which prepare graduates for essential administrative roles in hospitals, clinics, and insurance companies.

Nursing remains a high-demand profession with many online entry points. You can explore cheap online fnp programs if you have a nursing background and want to become a Family Nurse Practitioner, or consider affordable nursing programs online to become an RN or advance your credentials.

Each of these pathways offers flexibility, lower tuition costs, and great career potential in the dynamic U.S. healthcare system.

Best Scientists Citing Alan J. Garber

Recently Published Articles